What type of medicine does Acotiamide belong to?

Acotiamide (Acotiamide) is a drug with acetylcholinesterase inhibitor as its main pharmacological classification. It is mainly used clinically to treat functional dyspepsia (FD). The main feature of this type of disease is that there are no organic lesions, but symptoms such as postprandial fullness, abdominal discomfort, upper abdominal distension and even early satiety. Traditional gastromotility drugs are mostly dopamine receptor antagonists or serotonin receptor agonists, but their efficacy and tolerability are not entirely ideal. The emergence of acotiamide provides patients with a new mechanism of action.

Its pharmacological effect is mainly through inhibiting the activity of cholinesterase, thereby prolonging the action time of acetylcholine in the synaptic cleft and increasing the effectiveness of vagus nerve signal transmission. This can enhance the motility of gastrointestinal smooth muscles, speed up gastric emptying, and improve indigestion symptoms caused by lack of motivation. In addition, acotiamide can help relieve bloating and discomfort caused by patients staying in the stomach for too long after eating.

From a classification point of view, acotiamide is a member of gastrointestinal motility drugs , but unlike traditional drugs, it does not directly act on receptors, but improves gastrointestinal motility by indirectly enhancing the action of neurotransmitters, so it has fewer side effects and has a relatively mild impact on the central nervous system. When used clinically, it is mainly targeted at patients with functional dyspepsia, especially those with bothersome symptoms after meals, rather than patients with organic ulcers or severe gastric problems.

In summary, acotiamide is a new type of acetylcholinesterase inhibitor gastrointestinal motility drug that focuses on improving gastrointestinal motility disorders and provides a new treatment path for functional dyspepsia. Its unique mechanism of action gives it certain differentiated advantages among similar drugs.

Reference: https://www.rad-ar.or.jp/siori/english/search/result?n=33322